Group One Trading’s Lantern Pharma LTRN Stock Holding History

Group One Trading’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,000	Closed	-$9.09K	–	8258
2025 Q4	$9.09K	Sell	3,000 -700	-19%	-$2.61K	﹤0.01%	6860
2025 Q3	$16.1K	Hold	3,700	–	–	﹤0.01%	6857
2025 Q2	$11.7K	Buy	+3,700	New	+$12.5K	﹤0.01%	6619
2024 Q2	–	Sell	-300	Closed	-$2.64K	–	7162
2024 Q1	$2.64K	Buy	+300	New	+$1.6K	﹤0.01%	6423
2022 Q4	–	Sell	-1,200	Closed	-$6K	–	7730
2022 Q3	$6K	Buy	1,200 +400	+50%	+$2.15K	﹤0.01%	6751
2022 Q2	$5K	Hold	800	–	–	﹤0.01%	7106
2022 Q1	$6K	Buy	800 +100	+14%	+$668	﹤0.01%	7378
2021 Q4	$6K	Buy	+700	New	+$6.39K	﹤0.01%	7581

Other funds holding LTRN

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Group One Trading's LTRN Position: Q1 2026 in Review

Group One Trading reduced its Lantern Pharma (LTRN) stake by 99% in Q1 2026, selling an estimated $11.3K and leaving 23 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #7456.

Group One Trading first reported a position in LTRN in Q2 2025 and has held it in 4 quarters since. The position peaked at $22.1K in Q3 2025. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

Group One Trading held 23 shares of Lantern Pharma worth $32 as of Q1 2026.
Group One Trading sold 4,049 Lantern Pharma shares in Q1 2026, an estimated $11.3K.
Lantern Pharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7456 holding.
Group One Trading first reported a position in Lantern Pharma in Q2 2025 and has held it in 4 quarters since.
Group One Trading's Lantern Pharma position peaked at $22.1K in Q3 2025.
33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.